About Sprout Pharmaceuticals
Sprout Pharmaceuticals is a company based in Raleigh (United States) founded in 2011 was acquired by Bausch Health in August 2015. Sprout Pharmaceuticals has raised $185.16 million across 10 funding rounds from investors including Bausch Health. The company has 31 employees as of December 31, 2015. Sprout Pharmaceuticals offers products and services including Women's Health Products. Sprout Pharmaceuticals operates in a competitive market with competitors including Hope Medicine, Rejoni, ObsEva, Gameto and Forendo Pharma, among others.
- Headquarter Raleigh, United States
- Employees 31 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sprout Pharmaceuticals, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$185.16 M (USD)
in 10 rounds
-
Latest Funding Round
$10.56 M (USD), Series D
Dec 10, 2024
- Investors
-
Employee Count
31
as on Dec 31, 2015
-
Acquired by
Bausch Health
(Aug 20, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sprout Pharmaceuticals
Sprout Pharmaceuticals offers a comprehensive portfolio of products and services, including Women's Health Products.
Innovative solutions for women's sexual health advancements
People of Sprout Pharmaceuticals
Unlock access to complete
Funding Insights of Sprout Pharmaceuticals
Sprout Pharmaceuticals has successfully raised a total of $185.16M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10.56 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sprout Pharmaceuticals
Sprout Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Bausch Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Locked | Locked | Locked |
Investor details for Sprout Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sprout Pharmaceuticals
Investment portfolio details for Sprout Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sprout Pharmaceuticals
Detailed financials for Sprout Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sprout Pharmaceuticals Comparisons
Peer comparison for Sprout Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sprout Pharmaceuticals
Sprout Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hope Medicine, Rejoni, ObsEva, Gameto and Forendo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for fertility and menopause treatments are developed.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for reproductive health are developed.
|
Detailed competitors of Sprout Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sprout Pharmaceuticals
Complete news archive for Sprout Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sprout Pharmaceuticals
Sprout Pharmaceuticals was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Sprout Pharmaceuticals is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Sprout Pharmaceuticals is a funded company, having raised a total of $185.16M across 10 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Sprout Pharmaceuticals is 31.
Sprout Pharmaceuticals was founded in 2011 and is headquartered in Raleigh, United States. Operations focus on the pharmaceutical sector, particularly womens health. An FDA-approved, non-hormonal medication named ADDYI has been developed to address hypoactive sexual desire disorder in premenopausal women. The companys efforts center on drug development for this specific medical condition.
Sprout Pharmaceuticals's top competitors include Rejoni, Hope Medicine and Gameto.
Sprout Pharmaceuticals offers Women's Health Products.
Sprout Pharmaceuticals has 1 investor. Key investors include Bausch Health.